Is sermorelin a steroid? It isn't. Sermorelin is a peptide, a short chain of amino acids, that copies part of the body's natural signal for releasing growth hormone. It is not testosterone, an anabolic steroid, or human growth hormone (HGH) itself.
The confusion makes sense. Sermorelin is discussed in gyms, it affects a hormone pathway, and it appears on sports drug-testing lists. Those facts can make unlike substances sound interchangeable. They aren't. A broader comparison of peptides and steroids covers the chemistry; here is the sermorelin-specific answer.
Is sermorelin a steroid? The three categories
The cleanest way to sort this out is to ask what the substance is and where it acts.
| Category | What it is | What it does first | Is sermorelin in this category? |
|---|---|---|---|
| Anabolic steroid | A synthetic relative of testosterone | Activates the androgen receptor, the cell's docking point for testosterone-like signals | No |
| HGH | Growth hormone supplied directly | Activates growth-hormone receptors in tissues | No |
| GH secretagogue | A substance that prompts the body to release its own growth hormone | Sends a release signal to the pituitary | Yes |
“Secretagogue” simply means a substance that prompts secretion. Sermorelin is more specifically a GHRH analogue: a lab-made version of growth hormone-releasing hormone, the message the brain normally uses to tell the pituitary to release growth hormone. The pituitary is the small gland beneath the brain that makes and releases several hormones.
That makes sermorelin upstream of HGH. It delivers the message; HGH is the hormone released after the message. It also has no testosterone-like structure and does not work through the androgen receptor. The sermorelin-versus-HGH comparison goes deeper into that distinction.
What sermorelin actually does
Sermorelin contains 29 amino acids matching the active front portion of natural GHRH. A pharmacology review describes it as GHRH(1-29) and reports that the peptide is cleared from blood quickly, in roughly 10 to 20 minutes (Esposito et al., Advanced Drug Delivery Reviews, 2003). A short time in the blood does not mean nothing happens. The signal can still prompt a growth-hormone pulse.
A small 1984 study helps show the difference between sending the signal and giving HGH directly. Five healthy volunteers received several lengths of growth hormone-releasing factor, including the 29-amino-acid form. Growth hormone rose significantly compared with placebo and peaked 15 to 30 minutes later (Losa et al., Klinische Wochenschrift, 1984). This was a hormone-response experiment, not evidence that sermorelin builds muscle or improves athletic performance.
After growth hormone is released, it can raise IGF-1, or insulin-like growth factor 1, a hormone that carries some of growth hormone's signals into tissues. That shared pathway explains why sermorelin and HGH may raise some of the same monitoring questions even though they are different substances.
Not a steroid does not mean a shortcut to muscle
The phrase “not a steroid” answers a chemistry question. It does not prove that sermorelin produces steroid-like muscle gains, and it does not make every claim around the peptide reliable.
As of September 6, 2026, the day this article was written, a peer-reviewed review published June 18, 2026, described sermorelin as a GHRH analogue and found that meaningful benefits in healthy people remain uncertain because the human evidence is limited and mostly indirect (Dominikowski et al., Frontiers in Endocrinology, 2026). The same review noted possible growth-hormone-axis effects such as fluid retention, joint or muscle symptoms, changes in blood sugar, and injection-site reactions across the compounds it examined.
That is the useful middle ground. Sermorelin is not an anabolic steroid, but it still changes hormone signaling and deserves real medical screening and follow-up. Sermorelin side effects explains what has been reported and which symptoms warrant a call to the prescriber.
Why sermorelin still matters in drug testing
A substance does not have to be a steroid to be prohibited in tested sport. The World Anti-Doping Agency's 2026 Prohibited List, effective January 1, names sermorelin under S2.2.4, growth hormone-releasing factors. That section is separate from S1, the anabolic-agent section.
The list marks S2 substances as prohibited at all times, meaning both in and out of competition. That can affect professional, collegiate, masters, and amateur athletes whose organization follows WADA-style rules. A prescription by itself does not erase the rule. A tested athlete may need a therapeutic use exemption, or TUE, which is formal permission from the relevant anti-doping organization for a medically necessary prohibited substance.
Tesamorelin appears in the same WADA subsection because it is also a GHRH analogue. That shared placement does not make either peptide a steroid; it means both can influence the growth-hormone pathway.
What prescribed sermorelin means
There is no FDA-approved sermorelin product currently marketed. Geref was approved for pediatric growth-hormone deficiency and diagnostic testing, then its approvals were withdrawn in 2009. FDA later determined that the withdrawal was not for safety or effectiveness reasons (Federal Register, March 4, 2013).
Sermorelin is dispensed through Promise as a compounded medication, which is different from an FDA-approved product: the formulation offered here is not FDA-approved. Compounding means a licensed pharmacy prepares a medication for an individual prescription; it is not the same product as the discontinued brand.
A licensed provider may still prescribe a compounded formulation; that decision is between the patient and the doctor, and at Promise every request is reviewed, so not everyone qualifies. The review matters because “not a steroid” is only the beginning of the safety conversation. Medical history, current medicines, hormone-related conditions, goals, and participation in drug-tested sport can all change the decision.